{{Rsnum
|rsid=7228133
|Chromosome=18
|position=4539085
|Orientation=plus
|GMAF=0.1846
|Assembly=GRCh37.p10
|GenomeBuild=37.5
|dbSNPBuild=138
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 76.1 | 21.2 | 2.7
| HCB | 53.3 | 40.1 | 6.6
| JPT | 54.9 | 39.8 | 5.3
| YRI | 65.3 | 29.3 | 5.4
| ASW | 68.4 | 29.8 | 1.8
| CHB | 53.3 | 40.1 | 6.6
| CHD | 60.6 | 32.1 | 7.3
| GIH | 72.3 | 26.7 | 1.0
| LWK | 65.5 | 27.3 | 7.3
| MEX | 67.2 | 27.6 | 5.2
| MKK | 56.4 | 37.8 | 5.8
| TSI | 68.6 | 30.4 | 1.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=C
  |Pval=2E-6
  |OR=1.26
  |ORtxt=[1.034-1.522]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}